Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates

N Engl J Med. 2020 Nov 26;383(22):2188. doi: 10.1056/NEJMc2029828.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents* / adverse effects
  • Diphosphonates / adverse effects
  • Femoral Fractures* / chemically induced
  • Femoral Fractures* / prevention & control
  • Femur
  • Humans

Substances

  • Bone Density Conservation Agents
  • Diphosphonates